机译:响应胰岛自身抗原呈递而产生的白介素-1β以耐受性免疫治疗的时机以调节性T细胞的影响来区分T辅助17细胞。
The University of Queensland Diamantina Institute, Princess Alexandra Hospital, Brisbane, Queensland, Australia;
The University of Queensland Diamantina Institute, Princess Alexandra Hospital, Brisbane, Queensland, Australia;
The University of Queensland Diamantina Institute, Princess Alexandra Hospital, Brisbane, Queensland, Australia;
The University of Queensland Diamantina Institute, Princess Alexandra Hospital, Brisbane, Queensland, Australia;
The University of Queensland Diamantina Institute, Princess Alexandra Hospital, Brisbane, Queensland, Australia;
Queensland Clinical Trials and Biostatistics Centre, School of Population Health, The University of Queensland, Princess Alexandra Hospital, Brisbane, Queensland, Australia;
Islet Biology Laboratory, St. Vincent's Institute, Melbourne, Australia;
Autoimnumity and Transplantation Division, Walter and Eliza Hall Institute, Melbourne, Australia;
Autoimnumity and Transplantation Division, Walter and Eliza Hall Institute, Melbourne, Australia;
The University of Queensland Diamantina Institute, Princess Alexandra Hospital, Brisbane, Queensland, Australia;
The University of Queensland Diamantina Institute, Princess Alexandra Hospital, Brisbane, Queensland, Australia;
机译:响应胰岛自身抗原呈递而产生的白介素-1β以调节性T细胞为代价使T辅助17细胞分化:耐受性免疫疗法的时机。
机译:调节性T细胞抑制结肠炎的发展,阻止T辅助物17向其他T辅助物1细胞的分化。
机译:慢性炎症性牙周病中的前叉盒P3阳性调节性T细胞和白介素17阳性T辅助17细胞
机译:响应胰岛自身抗原呈递而产生的白介素-1β以调节性T细胞为代价区分了T-helper 17细胞。
机译:响应胰岛自身抗原呈递而产生的白介素-1β以调节性T细胞的费用区分了T-helper 17细胞:对耐受性免疫治疗时间的影响